Vaccine Therapy in Treating Women With Metastatic Breast Cancer
Phase 3
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2004-05-03
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Oncothyreon Canada Inc.
- Target Recruit Count
- 950
- Registration Number
- NCT00003638
- Locations
- 🇨🇦
Biomira Inc., Edmonton, Alberta, Canada
Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients
Phase 2
Completed
- Conditions
- Breast Neoplasms
- First Posted Date
- 2002-10-10
- Last Posted Date
- 2008-01-23
- Lead Sponsor
- Oncothyreon Canada Inc.
- Registration Number
- NCT00046371
© Copyright 2025. All Rights Reserved by MedPath